Tirzepatide - 1mg

REF #: TM-TP1111
Unit of measure
Short description

Tirzepatide: Unlock the Dual Receptor Agonist Advantage

Tirzepatide, a cutting-edge dual GIP and GLP-1 receptor agonist (RA), offers a groundbreaking solution for your research needs. This high-purity (98%) compound, with the CAS number 2023788-19-2, boasts a molecular weight of 4813.45g/mol and a solid color form. Meticulously crafted, Tirzepatide's unique peptide sequence unlocks the potential of dual receptor activation, providing a versatile tool for exploring novel therapeutic avenues. Handle with care, as it carries P111 hazard statements, and store securely at -20°C for long-term stability. Elevate your research with the power of Tirzepatide, a true game-changer in the world of dual receptor agonists.

Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years

Tirzepatide: Unlocking the Dual Potential of GIP and GLP-1 Receptor Agonism

Tirzepatide, a groundbreaking compound with the CAS number 2023788-19-2, represents a significant advancement in the realm of dual GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonism. This innovative molecule, designated as TM-TP1111, holds the promise of revolutionizing the way we approach the management of various metabolic conditions, from type 2 diabetes to obesity.

At the heart of tirzepatide's remarkable capabilities lies its unique dual-agonist mechanism of action. By simultaneously activating both the GIP and GLP-1 receptors, this compound harnesses the synergistic benefits of these two key incretin hormones. GIP plays a crucial role in stimulating insulin secretion, while GLP-1 enhances glucose-dependent insulin release and suppresses glucagon production. The combined activation of these pathways by tirzepatide results in improved glycemic control, reduced appetite, and enhanced weight management – a trifecta of therapeutic benefits that can significantly improve the quality of life for individuals struggling with metabolic disorders.

Unparalleled Purity and Precision

Tirzepatide, with its impressive purity of 98%, is a testament to the meticulous attention to detail and quality control measures employed in its synthesis. Its chemical formula, C225H348N48O68, and molecular weight of 4813.45 g/mol, underscore the compound's structural complexity and the expertise required to produce it consistently at such a high level of purity.

The solid, white appearance of tirzepatide further reinforces its exceptional quality, ensuring reliable and reproducible results in research and clinical applications. This level of purity and consistency is crucial for researchers and healthcare professionals who demand the utmost precision in their work, whether it's in the development of novel therapies or the advancement of scientific understanding.

Diverse Applications and Potential

The versatility of tirzepatide extends far beyond its primary application in the management of metabolic disorders. As a dual GIP and GLP-1 receptor agonist, this compound holds immense promise in the fields of pharmaceutical research and development.

In the realm of drug discovery, tirzepatide serves as a valuable tool for exploring new therapeutic avenues. Its unique mechanism of action and potent effects on glucose homeostasis and weight regulation make it a prime candidate for the development of innovative treatments for a wide range of conditions, including type 2 diabetes, obesity, and potentially even neurological disorders and cardiovascular diseases.

Beyond the pharmaceutical industry, tirzepatide's potential also extends to the agrochemical sector. Its ability to modulate metabolic pathways and influence weight management may contribute to the development of advanced crop protection agents, enhancing agricultural productivity and sustainability.

Comprehensive Safety and Handling

Tirzepatide, like any potent compound, requires careful handling and storage to ensure the safety of researchers and end-users. The hazard information associated with this molecule, including the P111 and P111 precautionary statements, underscores the need for appropriate personal protective equipment and adherence to established safety protocols.

To maintain the integrity and stability of tirzepatide, it is recommended to store the powder form at -20°C for up to 3 years, or in a solvent at -80°C for up to 1 year. These precise storage conditions are crucial for preserving the compound's purity and efficacy, enabling researchers to consistently achieve reliable and reproducible results in their investigations.

Unlocking the Potential: Peptide Sequence and Further Exploration

The peptide sequence of tirzepatide, Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diac

  • Color form: Solid
  • Formula: C225H348N48O68
  • Long term storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year;
  • Molecular weight: 4813.45
  • Notes: Peptide Sequence: Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
  • P statements: P111:P111
  • Purity: 98%
All categories